• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Companies Company News

Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022

Inimfon Asifa by Inimfon Asifa
March 31, 2023
in Company News, Company Results, Sectors
Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022
Share on FacebookShare on TwitterShare on Linkedin

Key Highlights

• The company reports its profit/Loss for the year to be 250% lower compared to last year


Neimeth International Pharmaceuticals Plc has released its audited financial report for the period ended December 31st, 2022 reporting a profit/loss for the year of (N406) million.

This represents a 250% decrease from the N270 million which the company reported during the same period in 2021.

MoreStories

Meet the CEOs powering Nigeria’s top consumer goods stocks of 2025 

Guinness Nigeria targets sustained profit recovery, growth momentum – CEO 

May 11, 2026
Why analysts are recommending these FUGAZ Stocks as a buy this week

FUGAZ provision N2.36 trillion, as bad loans mount in 2025

May 11, 2026

Key details of the audited financial report are summarized below

Revenue

  •  December 2022: N3.6 billion
  •  December 2021: N3.04 billion
  •  Change: +19.7%

Gross profit

  • December 2022: N10.5 billion
  • December 2021: N9.2 billion
  • Change: -8.3%

Total operating profit/loss

  • December 2022: (N13.1) million
  • December 2021: N553 million
  • Change: -102%

Pre-tax profit/loss

  • December 2022: (N388) million
  • December 2021: N365 million
  • Change: -206%

 Profit/Loss for the year

  • December 2022: (N406) million
  • December 2021: N270 million
  • Change: -250%

Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: Neimeth International Pharmaceuticals
Inimfon Asifa

Inimfon Asifa

Next Post
Weekly Stock Update: Nigerian Exchange Group record growth w-o-w, up by 0.48%

The stock market closes positive with Market Capitalization down N99 billion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Luis Figo
rabafast
nairametrics




DUNS

Follow us on social media:

  • ABOUT US
  • CONTACT US
  • PRODUCTS
  • ANDROID APP
  • iOS APP
  • DISCLAIMER
  • CAREERS
  • PRIVACY POLICY

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics